Mark Collins
Ask VT AI
View News Summary
- TransUnion beats expectations, raises full-year outlook and provides Q4 guidance, driven by robust demand and improving profitability.
- Moderna halts development of its experimental CMV vaccine after Phase III trial fails to meet primary endpoint, leaving the field without an approved congenital CMV vaccine.
- VP Vance condemns Knesset's 'political stunt' vote to annex West Bank
20 hours

United States Politics
Discover the latest news, candidates, and key topics of US politics
Ask VT AI
View News Summary
- TransUnion beats expectations, raises full-year outlook and provides Q4 guidance, driven by robust demand and improving profitability.
- Moderna halts development of its experimental CMV vaccine after Phase III trial fails to meet primary endpoint, leaving the field without an approved congenital CMV vaccine.
- VP Vance condemns Knesset's 'political stunt' vote to annex West Bank
20 hours

United States Politics
Discover the latest news, candidates, and key topics of US politics
Most Reported By
News from Mark Collins
News from Mark Collins